Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank56
3Y CAGR-59.8%
5Y CAGR-31.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-59.8%/yr
Quarterly compound
5Y CAGR
-31.4%/yr
Recent deceleration
Percentile
P56
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 9.09% |
| Q2 2025 | -283.33% |
| Q1 2025 | 126.67% |
| Q4 2024 | -28.05% |
| Q3 2024 | -226.15% |
| Q2 2024 | 112.19% |
| Q1 2024 | -33.33% |
| Q4 2023 | -100.71% |
| Q3 2023 | 409.76% |
| Q2 2023 | -193.51% |
| Q1 2023 | 78.13% |
| Q4 2022 | -106.23% |
| Q3 2022 | 140.30% |
| Q2 2022 | 6.29% |
| Q1 2022 | 40.07% |
| Q4 2021 | 33.40% |
| Q3 2021 | -79.78% |
| Q2 2021 | 52.64% |
| Q1 2021 | -12.82% |
| Q4 2020 | -35.76% |
| Q3 2020 | 59.66% |
| Q2 2020 | -129.78% |
| Q1 2020 | -48.20% |
| Q4 2019 | 10.18% |
| Q3 2019 | 69.08% |
| Q2 2019 | -43.59% |
| Q1 2019 | -15.84% |
| Q4 2018 | 18.85% |
| Q3 2018 | 35.81% |
| Q2 2018 | 75.85% |
| Q1 2018 | -351.12% |
| Q4 2017 | -30.47% |
| Q3 2017 | 35.81% |
| Q2 2017 | 6.79% |
| Q1 2017 | -53.05% |
| Q4 2016 | 16.60% |
| Q3 2016 | 0.00% |